Lee Hyeong Ki

Lee Hyeong Ki
Lee Hyeong Ki

서울대학교의과대학 / 의학사
서울대학교의과대학원 / 예방의학 (역학) 의학석사
서울대학교의과대학원 / 예방의학 (역학) 의학박사
Center for Drug Development Science Clinical Pharmacology Fellows Georgetown University Medical Center / Postdoc Fellowship

2017-           서울대학교 임상약리학협동과정 대학원 주임교수
2014-           서울대학교 의과대학 임상약리학 교실, 서울대학교 융합과학기술대학원 융합과학부, 서울대학교 병원 임상약리학과 교수
2012-2017  서울대학교병원 임상시험센터 글로벌전략기획실장
2012-2014  서울대학교병원 임상시험센터/임상약리학과 임상교수
2006-2012   Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco (UCSF) Associate Professor
2006-2012   Center for Drug Development Science University of California, San Francisco (UCSF) Director
2010-2012   인제대학교 약물유전체연구센터,부산 백병원 임상약리학과 자문교수
2009-            서울대학교의과대학의약품산업의학고위과정 겸임교수
2006-            Therapeutic Drug Monitoring (Journal) Member, Editorial Board
2005-2006    Division of Clinical Pharmacology, Department of Medicine, University of Pittsburgh School of Medicine Assistant Professor
2005-2006    Clinical Investigation Core, Division of Clinical Pharmacology, Department of Medicine, University of Pittsburgh School of Medicine Director
2005-2006    University of Pittsburgh Hospitals (UPMC) Institutional Licensure (LT-000580) 펜실배니아주정부기관의사면허
2004-2004    US Food and Drug Administration, Course on Applying Exposure-Response Concepts in Drug Development Lecturer, Guest Researcher
2003-2005    Institutional Review Board, Georgetown University IRB Member
2002-2005    Department of Pharmacology, School of Medicine, Georgetown University   Assistant Professor
2001-2001    US Food and Drug Administration Guest Medical Reviewer
2000-2002    Center for Drug Development Science, School of Medicine, Georgetown University  Research Fellow
1996-2000    종근당㈜ 의학부임원 (이사)
1994-1996    한국엠에스디㈜ 학술개발부실장
1992-1994    대한민국 공군서울병원 병원장 겸 참모총장공관 주치의
1991-1992    대한민국공군, 제주도기지 의무실장
1989-1991    서울대학교병원, 가정의학과 레지던트
1988-1989    서울대학교병원 인턴


 

♦ Education

Seoul National University College of Natural Sciences / Premed (Premedical Sciences)
Seoul National University College of Medicine / MD (Medicine)
Seoul National University College of Medicine Graduate School / MSc (Epidemiology)
Seoul National University College of Medicine Graduate School / PhD (Epidemiology)
Center for Drug Development Science Clinical Pharmacology Fellows Georgetown University Medical Center / Postdoc Fellowship

 

♦ Professional

2017-           The Interdisciplinary Program of Clinical Pharmacology at Seoul National University / Head Professor
2014-           Department of Transdisciplinary Studies, Graduate  School of Convergence Science and Technology,Seoul National University / Professor
2012-2017  Global Strategy and Planning, Clinical Trials Center, Seoul National University Hospital / Head Professor
2012-2014  Seoul National University Hospital / Clinical Professor
2006-2012   Department of Bioengineering and Therapeutic Sciences, School of Pharmacy, University of California, San Francisco (UCSF) Associate Professor
2006-2012   Center for Drug Development Science University of California, San Francisco (UCSF) Director
2010-2012   Inje University College of Medicine, Division of Clinical Pharmacology / Distinguished Visiting Professor
2009-            Seoul National University College of Medicine Graduate School /Professor
2006-            Therapeutic Drug Monitoring (Journal) Member, Editorial Board
2005-2006    Division of Clinical Pharmacology, Department of Medicine, University of Pittsburgh School of Medicine Assistant Professor
2005-2006    Clinical Investigation Core, Division of Clinical Pharmacology, Department of Medicine, University of Pittsburgh School of Medicine Director
2005-2006    University of Pittsburgh Hospitals (UPMC) Institutional Licensure (LT-000580) Commonwealth of Pennsylvania, State Board of Medicine
2004-2004    US Food and Drug Administration, Course on Applying Exposure-Response Concepts in Drug Development Lecturer, Guest Researcher
2003-2005    Institutional Review Board, Georgetown University IRB Member
2002-2005    Department of Pharmacology, School of Medicine, Georgetown University   Assistant Professor
2001-2001    US Food and Drug Administration Guest Medical Reviewer
2000-2002    Center for Drug Development Science, School of Medicine, Georgetown University  Research Fellow
1996-2000    Chong Kun Dang Pharmaceutical Corp. / Director (Medical Department)
1994-1996    MSD Korea / Senior Manager(Medical Department)
1992-1994    Air Force Seoul Hospital / President
1991-1992    Cheju Radar Unit, Air Force Head / Medical Squadron
1989-1991    Seoul National University Hospital / Resident (Family Medicine)
1988-1989    Seoul National University Hospital / Intern

 

♦ HONORS AND AWARDS:

  • The Most Honorable Air Force Officer Award, Air Force, Korea (April, 1991 )
  • The Kochon Excellent Award for International Research in Pharmaceutical Medicine and Drug Development Science, Kochon Foundation, Seoul, Korea(December, 1999 )
  • 2003 Faculty Colloquium, Center for New Designs in Learning and Scholarship (CNDLS), Georgetown University, Washington, DC, USA (January, 2003)
  • Young Investigator’s Travel Award, The Pharmacokinetics, Pharmacodynamics and Drug MetabolismSection, The American Association of Pharmaceutical Scientists, USA(October, 2003 )
  • Fellow, The Summer Institute in Maternal-Fetal Pharmacology, Mont-Tremblant, Quebec, Canada (May, 2005 )
  • Member Award, American Society for Clinical Pharmacology and Therapeutics, USA (March, 2015 )

 

Dr. Howard Lee is the Founder and Director of the Center for Convergence Approaches in Drug Development (CCADD). Dr. Lee serves as a Professor at the Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University. Dr. Lee is also appointed at Seoul National University College of Medicine and Hospital, affiliated with the Department of Clinical Pharmacology and Therapeutics. Dr. Lee previously served as Head of Global Strategy and Planning, Clinical Trials Center, SNUH. As of August 2017, Dr. Lee was appointed Chair of the Graduate Program in Clinical Pharmacology, Seoul National University.

Dr. Lee is a board-certified physician in Family Medicine and Clinical Pharmacology and holds a PhD in Epidemiology. Dr. Lee completed a fellowship in Clinical Pharmacology at the Center for Drug Development Science (CDDS), Department of Pharmacology, Georgetown University School of Medicine in Washington DC, USA, where he subsequently served as an Assistant Professor of Medicine and eventually became Director after CDDS has joined the University of California San Francisco in association with the School of Pharmacy. Dr. Lee also had served as faculty in two other US-based universities including the University of California San Francisco and the University of Pittsburgh.

 

Dr. Lee’s professional career consists of an interesting mix of academia, industry, and government. Before he went to the US, Dr. Lee had a 5 year real-world experience in clinical drug development at two pharmaceutical companies as Medical Director. Dr. Lee also was a Guest Researcher at the Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration.

 

Dr. Lee was the co-principal investigator for clinical pharmacology of the Washington Obstetric Pharmacology Research Unit Network grant (NIH HD-03-017) affiliated with Georgetown University Medical Center. Dr. Lee also served as a co-investigator of the Collaborative Pediatric Pharmacology Research Unit Network grant (NIH HD-03-001). Dr. Lee was the principal investigator of the Merck Foundation Grant, entitled “A Systematic Policy Analysis to Identify Key Strategies for Implementing Good Review Practices into the Korea Food and Drug Administration”.

 

Since returning to Korea in late 2012, Dr. Lee has served as the principal investigator in >15 clinical pharmacology studies including six first-in-human studies. Furthermore, Dr. Lee has spearhead the introduction of Accelerator Mass Spectrometry (AMS)-enabled exploratory early clinical drug development studies to the Korean biopharmaceutical R&D sector, which has awarded Dr. Lee two government grants.

 

Dr. Lee is well-versed in pharmacometrics, clinical trials design, drug development science, and drug regulations (Korea and the US). Dr. Lee’s current research interests are first-in-human studies of new drugs including biologics, AMS-based microdosing and microtracer studies, pharmacokinetic-pharmacodynamic modeling, regulatory issues related to biosimilar products, and, lastly but not the least, artificial intelligence to streamline clinical drug development practices.

 

Back